Zofia Hélias‐Rodzewicz

Author

Also Known As

Delphine Lecorre, Hélias-Rodzewicz, Zofia, Z Hélias-Rodzewicz, Z. Helias-Rodzewicz, Z. Helias‐Rodzewicz, Z. Hélias-Rodzewicz, Zofia Helias-Rodzewicz, Zofia Helias‐Rodzewicz, Zofia Hélias-Rodzewicz, Zofia Hélias‐Rodzewicz

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Hôpital Ambroise-Paré Inserm Assistance Publique – Hôpitaux de Paris Sorbonne Université Université Paris-Saclay

About

Zofia Hélias‐Rodzewicz is an author at Hôpital Ambroise-Paré specializing in pathology, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	467
2	Pathology	5	5	467
3	Cell Biology	1	1	21
4	Immunology	1	1	172
5	Surgical Oncology	1	1	92

Zofia Hélias‐Rodzewicz

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses Julien Haroche, Frédéric Charlotte, Laurent Arnaud, Blood	2012	682
<i>BRAF</i> Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy Sébastien Heritier, Jean‐François Emile, Mohamed‐Aziz Barkaoui, Journal of Clinical Oncology	2016	327
Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease Jean‐François Emile, Eli L. Diamond, Zofia Hélias‐Rodzewicz, Blood	2014	242
Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study Jean Donadieu, Islam Amine Larabi, M. Tardieu, Journal of Clinical Oncology	2019	210
Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab Adrien Costantini, Catherine Julié, Coraline Duménil, OncoImmunology ImmunologyImmunoeditingPathologyImmunotherapeuticsLow Sgranb	2018	172
Mutational signature analysis identifies <i><scp>MUTYH</scp></i> deficiency in colorectal cancers and adrenocortical carcinomas Camilla Pilati, Jayendra Shinde, Ludmil B. Alexandrov, The Journal of Pathology	2017	159
Detection of BRAF p.V600E Mutations in Melanomas Émeline Colomba, Zofia Hélias‐Rodzewicz, Andreas von Deimling, Journal of Molecular Diagnostics MedicineBraf P.v600e MutationsMelanomaPathologyCancer Genomics	2012	157
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition Paul G. Kemps, Jennifer Picarsic, Benjamin H. Durham, Blood	2021	144
High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis Matthias Papo, Eli L. Diamond, Fleur Cohen‐Aubart, Blood	2017	143
Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells Benjamin H. Durham, Damien Roos‐Weil, Claude Baillou, Blood	2017	128

Page 1